HALOZYME THERAPEUTICS INC (HALO)

Overview Price 11.11 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $11.11 Daily Range $0.00 - $0.00 52-Week Range $5.54 - $11.62 Volume 2,300 Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine. Other Resources for HALO Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Update on VPHM's Industrial Facility February 9, 2012 Zacks Blog: Zacks.com featured expert Kevin Matras highlights: Brookfield Office Properties Inc., Fiserv, Inc., Halozyme Therapeutics, Inc., Jacobs Engineering Group Inc. and MarketAxess Holdings Inc. January 17, 2012 Zacks Blog: Priority Review for VPHM's Drug January 16, 2012 Zacks Blog: ViroPharma's Seizure Drug Reaches UK December 14, 2011 Zacks Blog: ViroPharma-Halozyme Drug Advances December 7, 2011 Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.   Brokerage Analyst Recommendations 8 Brokerage Firms Covering HALO   Strong Buy 8 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   HALO Ratings: BUY  SELL  HOLD HALO Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 9 Buy 2 Sell   Top Buy Analysis BUY: HALO Company: HALOZYME THERAPEUTICS INC. Points: 15.31 Start Price: $8.48 Start Date: 03/23/2010 7:12 AM Sooner P&P Score: 1.60 Recs: Ready for a nice move Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: HALO Company: HALOZYME THERAPEUTICS INC. Points: -72.75 Start Price: $6.71 Start Date: 01/01/2008 12:00 AM rlenz P&P Score: 27.37 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	02/09/12	Update on VPHM's Industrial Facility - Analyst Blog	0
Zacks_Analysts	0.00	01/16/12	Priority Review for VPHM's Drug - Analyst Blog	0
Zacks_Analysts	0.00	01/09/12	Covidien Wraps up BARRX Buy - Analyst Blog	0
Zacks_Analysts	0.00	12/14/11	ViroPharma's Seizure Drug Reaches UK - Analyst Blog	0
Zacks_Analysts	0.00	12/07/11	ViroPharma-Halozyme Drug Advances - Analyst Blog	0
Zacks_Analysts	0.00	11/23/11	Covidien Snaps Up BARRX Medical - Analyst Blog	0
Zacks_Analysts	0.00	11/08/11	Autodesk Gets GRIP Entertainment - Analyst Blog	0
Zacks_Analysts	0.00	10/31/11	ViroPharma Going Strong - Analyst Blog	0
Zacks_Analysts	0.00	10/12/11	AutoDesk Tools for Gears of War - Analyst Blog	0
Zacks_Analysts	0.00	09/15/11	ViroPharma, Halozyme Initiate Trial - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $8.48 Points: +15.31 Created: 03/23/2010 Ready for a nice move Comments: 0 | Comment Sooner Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $10.31 Points: +4.56 Created: 01/23/2012 Comments: 0 | Comment Radarvector Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $4.99 Points: +84.41 Created: 10/08/2008 Comments: 0 | Comment OpeningBell Recs:

SELL: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $6.71 Points: -72.75 Created: 01/01/2008 Comments: 0 | Comment rlenz Recs:

SELL: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $7.03 Points: -65.25 Created: 01/01/2008 Comments: 0 | Comment attic_bathe Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $4.58 Points: +149.41 Created: 01/01/2008 Comments: 0 | Comment knuckking Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $5.61 Points: +105.07 Created: 01/01/2008 Comments: 0 | Comment kysoti10 Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $4.27 Points: +166.94 Created: 01/01/2008 Comments: 0 | Comment eloy Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $9.50 Points: +24.34 Created: 01/01/2008 Comments: 0 | Comment Cath Recs:

BUY: HALOZYME THERAPEUTICS INC. (HALO) Start Price: $8.29 Points: +41.34 Created: 01/01/2008 Comments: 0 | Comment JimmyG Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Radarvector	99.11	BUY	Week or Less	01/23/2012	$10.31	$11.06 (-1.95%)	+7.28%	+2.71%	+4.56
Sooner	1.60	BUY	One to Three Months	03/23/2010	$8.48	$11.06 (-1.95%)	+30.43%	+15.12%	+15.31	view close
OpeningBell	43.35	BUY	Three to Six Months	10/08/2008	$4.99	$11.06 (-1.95%)	+121.65%	+37.23%	+84.41
rlenz	27.37	SELL	Six Months to a Year	01/01/2008	$6.71	$11.06 (-1.95%)	+64.83%	-7.92%	-72.75
attic_bathe		SELL	Six Months to a Year	01/01/2008	$7.03	$11.06 (-1.95%)	+57.33%	-7.92%	-65.25
knuckking	72.43	BUY	Six Months to a Year	01/01/2008	$4.58	$11.06 (-1.95%)	+141.49%	-7.92%	+149.41
kysoti10	45.76	BUY	Six Months to a Year	01/01/2008	$5.61	$11.06 (-1.95%)	+97.15%	-7.92%	+105.07
eloy	40.97	BUY	Six Months to a Year	01/01/2008	$4.27	$11.06 (-1.95%)	+159.02%	-7.92%	+166.94
Cath	85.51	BUY	Six Months to a Year	01/01/2008	$9.50	$11.06 (-1.95%)	+16.42%	-7.92%	+24.34
JimmyG		BUY	Six Months to a Year	01/01/2008	$8.29	$11.06 (-1.95%)	+33.41%	-7.92%	+41.34

Pages: [ 1 ]  2  >>